Cargando…

Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease

BACKGROUND: Chagas disease, caused by Trypanosoma cruzi, is endemic in Latin America and an emerging infectious disease in the US and Europe. We have shown TcG1, TcG2, and TcG4 antigens elicit protective immunity to T. cruzi in mice and dogs. Herein, we investigated antigenicity of the recombinant p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Shivali, Wan, Xianxiu, Zago, Maria P., Martinez Sellers, Valena C., Silva, Trevor S., Assiah, Dadjah, Dhiman, Monisha, Nuñez, Sonia, Petersen, John R., Vázquez-Chagoyán, Juan C., Estrada-Franco, Jose G., Garg, Nisha Jain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547861/ https://www.ncbi.nlm.nih.gov/pubmed/23350012 http://dx.doi.org/10.1371/journal.pntd.0002018

Ejemplares similares

MnSOD(tg) Mice Control Myocardial Inflammatory and Oxidative Stress and Remodeling Responses Elicited in Chronic Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis
por: Dhiman, Monisha, et al.
Publicado: (2012)

Innate Immune Responses and Antioxidant/Oxidant Imbalance Are Major Determinants of Human Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

Oxidative Stress in Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2009)

Defects of mtDNA Replication Impaired Mitochondrial Biogenesis During Trypanosoma cruzi Infection in Human Cardiomyocytes and Chagasic Patients: The Role of Nrf1/2 and Antioxidant Response
por: Wan, Xianxiu, et al.
Publicado: (2012)

Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease
por: Garg, Nisha Jain, et al.
Publicado: (2016)

Origin of Monocytes/Macrophages Contributing to Chronic Inflammation in Chagas Disease: SIRT1 Inhibition of FAK-NFκB-Dependent Proliferation and Proinflammatory Activation of Macrophages
por: Wan, Xianxiu, et al.
Publicado: (2019)

P47(phox−/−) Mice Are Compromised in Expansion and Activation of CD8(+) T Cells and Susceptible to Trypanosoma cruzi Infection
por: Dhiman, Monisha, et al.
Publicado: (2014)

TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization
por: Gupta, Shivali, et al.
Publicado: (2019)

SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease
por: Wan, Xianxiu, et al.
Publicado: (2016)

Testing the Efficacy of a Multi-Component DNA-Prime/DNA-Boost Vaccine against Trypanosoma cruzi Infection in Dogs
por: Aparicio-Burgos, José E., et al.
Publicado: (2011)

Potential Utility of Protein Targets of Cysteine-S-Nitrosylation in Identifying Clinical Disease Status in Human Chagas Disease
por: Zago, Maria Paola, et al.
Publicado: (2019)

Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy
por: Choudhuri, Subhadip, et al.
Publicado: (2021)

Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression
por: Gupta, Shivali, et al.
Publicado: (2015)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Manganese superoxide dismutase deficiency exacerbates the mitochondrial ROS production and oxidative damage in Chagas disease
por: Wen, Jake J., et al.
Publicado: (2018)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance
por: Wen, Jake Jianjun, et al.
Publicado: (2018)

Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Human Trypanosoma cruzi Infection and Seropositivity in Dogs, Mexico
por: Estrada-Franco, Jose G., et al.
Publicado: (2006)

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease
por: Sánchez-Villamil, Juana P., et al.
Publicado: (2020)

Pentose Phosphate Shunt Modulates Reactive Oxygen Species and Nitric Oxide Production Controlling Trypanosoma cruzi in Macrophages
por: Koo, Sue-jie, et al.
Publicado: (2018)

Prophylactic Efficacy of TcVac2 against Trypanosoma cruzi in Mice
por: Gupta, Shivali, et al.
Publicado: (2010)

TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
por: Gupta, Shivali, et al.
Publicado: (2013)

Fexinidazole: A Potential New Drug Candidate for Chagas Disease
por: Bahia, Maria Terezinha, et al.
Publicado: (2012)

Perspectives for a new drug candidate for Chagas disease therapy
por: Soeiro, Maria de Nazaré Correia
Publicado: (2022)

Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection
por: Lokugamage, Nandadeva, et al.
Publicado: (2020)

Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
por: Sesti-Costa, Renata, et al.
Publicado: (2014)

Immune Protection against Trypanosoma cruzi Induced by TcVac4 in a Canine Model
por: Aparicio-Burgos, José E., et al.
Publicado: (2015)

Redox Balance Keepers and Possible Cell Functions Managed by Redox Homeostasis in Trypanosoma cruzi
por: Mesías, Andrea C., et al.
Publicado: (2019)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

S-Nitrosylation Proteome Profile of Peripheral Blood Mononuclear Cells in Human Heart Failure
por: Koo, Sue-jie, et al.
Publicado: (2016)

Causas de la diferencia poblacional masculina y femenina en los talleres culturales de la fes Cuautitlán, UNAM
por: Vázquez Chagoyán, Victor Raúl
Publicado: (2008)

Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease
por: Lokugamage, Nandadeva, et al.
Publicado: (2021)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Enfermedades de chagas :a propósito de un caso, revisión y actualización bibliográfica del tema/
por: Santamaría Vázquez, Edith

Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
por: Arce-Fonseca, Minerva, et al.
Publicado: (2018)

A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi
por: Gupta, Shivali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jasbt9gjel31o8ikot2u08bua2